Pharmac prioritized Māori and Pacific patients for access to new diabetes drugs—did they get it right?
The controversial 2021 decision by the government drug-buying agency Pharmac to prioritize Māori and Pacific patients in its funding of two game-changing new diabetes drugs appears to have paid off.
Mar 20, 2023
0
2